dihexa hgf c-met mechanism

dihexa hgf c-met mechanism Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity Design and Synthesis of c-Met

Name: dihexa hgf c-met mechanism Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity Design and Synthesis of c-Met
Brand: webdevsolutions.tech
SKU: 81315051859
Price: 28.91 USD
Availability: InStock
Rating: 4.072 (20 reviews)

Design and Synthesis of c Met and HDAC Dual Inhibitors for the Treatment of Breast Cancer ACS Medicinal Chemistry Letters A novel agonist for the HGF receptor MET promotes differentiation of human pluripotent stem cells into hepatocytelike cells Tauran 2022 Development, Growth & Differentiation Wiley Online Library dihexa hgf c met cancer risk Role of the HGF c MET tyrosine kinase inhibitors in Molecular mechanism(s) of regulation(s) of c MET: A Key Target in Cancer Therapy

SKU: 81315051859 · From webdevsolutions.tech

4.1

USD28.91 USD68.91

Pay in 4 interest-free payments of $7.23 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

Description

Enhanced Bioavailability and Systemic Reach Injecting BPC-157 directly into subcutaneous tissue ensures high bioavailability , avoiding enzymatic degradation